Little is known about the
prevalence of cervical cancer screening (CCS) and its correlates among homeless
women in France. The objectives of this study were to determine the prevalence
of women who had never been screened for cervical cancer and to identify the
associated factors.
This cross-sectional study was based on data collected in
the ENFAMS survey, which was conducted in 2013 among 764 sheltered homeless
mothers in the Greater Paris Area. Robust Poisson regression models were used
to estimate the association between no lifetime CCS and certain
sociodemographic and health-related factors (selected from the behavioral model
of vulnerable populations).
Analyses were carried out separately for women with
and without a regular gynaecological follow-up (RGF). The proportion of
never-screeners was 33% among the women with an RGF versus 64% among those
without an RGF (P<0.001). Among the latter, never having been screened for
CCS was associated mainly with socioeconomic conditions, the length of time
lived in France, a history of delivery in France and the duration of
homelessness.
In those with an RGF, the factors were mainly poor health service
utilization and language difficulties. This first quantitative study of CCS
among homeless women in the Greater Paris Area points to the need for it to be
proposed and performed more systematically in primary care.
Every contact
between this hard-to-reach population and health services should be an
opportunity to check their screening status and to ensure that those in need
actually undergo a Pap test.
Purchase full article at: http://goo.gl/pb8VmU
By:
- 1 Department of Social Epidemiology, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136)
- b Department of the Inter-Regional Epidemiological Autorithy, French Institute for Public Health Surveillance, Saint-Maurice
- c Department of General Practice, School of Medicine, Sorbonne Universities, UPMC Univ Paris 06, Paris, France.
- Eur J Cancer Prev. 2016 Feb 18.
More at: https://twitter.com/hiv insight
No comments:
Post a Comment